In patients with myeloproliferative neoplasms and murine models, the expression of the alarmin complex S100A8/S100A9, a crucial proinflammatory player in MPNs, in MSC mediates the disease progression toward the fibrotic phenotype. This evidence concerns the gene S100A9 and myeloproliferative disorder.